IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,769,157 | -15.9% | 300,514 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,670,699 | +411.6% | 300,514 | +4.1% | 0.00% | – |
| Q1 2023 | $1,108,470 | -22.6% | 288,664 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $1,431,773 | -7.6% | 288,664 | -10.9% | 0.00% | 0.0% |
| Q3 2022 | $1,549,000 | -28.3% | 324,073 | -32.5% | 0.00% | 0.0% |
| Q2 2022 | $2,161,000 | +57.3% | 480,321 | +66.4% | 0.00% | 0.0% |
| Q1 2022 | $1,374,000 | -35.7% | 288,664 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $2,136,000 | -9.1% | 287,864 | -30.5% | 0.00% | 0.0% |
| Q3 2021 | $2,350,000 | +23.9% | 414,471 | +44.0% | 0.00% | 0.0% |
| Q2 2021 | $1,897,000 | -18.7% | 287,864 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,332,000 | +25.6% | 287,864 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,857,000 | +79.2% | 287,864 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,036,000 | -24.3% | 287,864 | -3.3% | 0.00% | 0.0% |
| Q2 2020 | $1,369,000 | +38.0% | 297,564 | +2.3% | 0.00% | 0.0% |
| Q1 2020 | $992,000 | -33.2% | 290,964 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,485,000 | +92.6% | 290,964 | -8.7% | 0.00% | – |
| Q3 2019 | $771,000 | +7.5% | 318,664 | -3.5% | 0.00% | – |
| Q2 2019 | $717,000 | +19.3% | 330,264 | +49.0% | 0.00% | – |
| Q1 2019 | $601,000 | -62.9% | 221,664 | -34.3% | 0.00% | -100.0% |
| Q4 2018 | $1,620,000 | -20.5% | 337,444 | +56.8% | 0.00% | 0.0% |
| Q3 2018 | $2,038,000 | -2.8% | 215,203 | -0.1% | 0.00% | 0.0% |
| Q2 2018 | $2,097,000 | +65.9% | 215,517 | +79.4% | 0.00% | 0.0% |
| Q1 2018 | $1,264,000 | +63.3% | 120,164 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $774,000 | -14.5% | 120,764 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $905,000 | +7.6% | 118,264 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $841,000 | +83.6% | 118,264 | 0.0% | 0.00% | – |
| Q1 2017 | $458,000 | +46.8% | 118,264 | -22.7% | 0.00% | – |
| Q4 2016 | $312,000 | -23.9% | 152,964 | 0.0% | 0.00% | – |
| Q3 2016 | $410,000 | -26.8% | 152,964 | -15.9% | 0.00% | – |
| Q2 2016 | $560,000 | -55.0% | 181,864 | +24.6% | 0.00% | -100.0% |
| Q1 2016 | $1,244,000 | -37.3% | 145,964 | -0.2% | 0.00% | -50.0% |
| Q4 2015 | $1,985,000 | +30.4% | 146,244 | -7.8% | 0.00% | +100.0% |
| Q3 2015 | $1,522,000 | -39.8% | 158,548 | -9.8% | 0.00% | -50.0% |
| Q2 2015 | $2,527,000 | +71.4% | 175,734 | +6.7% | 0.00% | +100.0% |
| Q1 2015 | $1,474,000 | +46.7% | 164,734 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,005,000 | -43.3% | 164,734 | -1.6% | 0.00% | 0.0% |
| Q3 2014 | $1,773,000 | -10.6% | 167,440 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $1,984,000 | -20.6% | 167,440 | -0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,500,000 | +1.8% | 167,451 | -0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,457,000 | -17.0% | 167,484 | -3.7% | 0.00% | -33.3% |
| Q3 2013 | $2,960,000 | -2.1% | 173,906 | -4.6% | 0.00% | 0.0% |
| Q2 2013 | $3,023,000 | – | 182,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |